Jade Biosciences Inc. AVTE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Jade Biosciences Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for inflammation and immunology indications in patients with autoimmune diseases. Its lead candidate, JADE101, is a monoclonal antibody designed to inhibit the cytokine APRIL (A Proliferation-Inducing Ligand) and …
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees55
TickerAVTE
Statistics
Market Cap$449.8M
Revenue (TTM)$0
Net Income-$69.6M
Net Margin—
EPS—
P/E—
P/S—
P/B—
EV/EBITDA-5.50
ROE-91.1%
Dividend Yield—
Price$15.52
Data: Twelve Data · Revenue = mcap / P/S